Beyond Air, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
XAIR Nasdaq 2836 www.beyondair.net

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Beyond Air, Inc.

Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) - Aug 31st, 2026 6:00 am
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments - Aug 25th, 2026 5:00 am
Beyond Air (XAIR) Q1 2027 Earnings Call Transcript - Aug 13th, 2026 9:58 pm
Beyond Air Inc (XAIR) (Q1 2027) Earnings Call Highlights: Strategic Financing and Pipeline ... - Aug 13th, 2026 5:09 pm
Beyond Air, Inc. Q1 2027 Earnings Call Summary - Aug 13th, 2026 3:08 pm
Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update - Aug 13th, 2026 5:00 am
Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026 - Aug 4th, 2026 6:00 am
Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules - Jul 30th, 2026 5:00 am
Beyond Air, Inc. Q4 2026 Earnings Call Summary - Jun 27th, 2026 6:30 am
Beyond Air (XAIR) Q4 2026 Earnings Call Transcript - Jun 26th, 2026 6:31 pm
Beyond Air Inc (XAIR) Q4 2026 Earnings Call Highlights: Revenue Surge and Path to Profitability - Jun 26th, 2026 1:00 pm
Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update - Jun 26th, 2026 5:00 am
Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast - Jun 22nd, 2026 2:01 pm
Beyond Air, Inc. Urges Stockholders to Vote “FOR” All Proposals Ahead of the Upcoming Special Meeting - Jun 10th, 2026 6:00 am
Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing - Jun 1st, 2026 6:00 am
Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026 - Apr 20th, 2026 6:00 am
Beyond Air to Participate in the D. Boral Capital Global Conference 2026 - Apr 15th, 2026 6:00 am
Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO) - Apr 1st, 2026 7:00 am